<p>Drägerwerk reported preliminary figures for full year 2025, achieving record net sales of EUR 3.5 billion, an increase of 3.3 percent. The medical division contributed around EUR 2.0 billion, rising 5.1 percent, while the safety division reached approximately EUR 1.5 billion, up 1.0 percent. The group’s gross margin improved to 45.4 percent for the year. Earnings before interest and taxes (EBIT) rose significantly to between EUR 226 and 236 million, with the EBIT margin increasing to a range of 6.5 to 6.8 percent. Drägerwerk expects net sales growth of 1.0 to 5.0 percent and an EBIT margin of 5.0 to 7.5 percent for 2026. The final 2025 annual report is scheduled for release on March 24, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drägerwerk AG &amp; Co. KGaA published the original content used to generate this news brief via EQS News, a service of EQS Group AG (Ref. ID: adhoc_2260714_en), on January 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

Drägerwerk posts FY 2025 net sales of EUR 3.5 billion, up 5.3%